AbCellera Biologics Inc (NASDAQ:ABCL) price on Wednesday, May 09, fall -4.95% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $3.84.
A look at the stock’s price movement, the close in the last trading session was $4.04. Turning to its 52-week performance, $8.05 and $3.62 were the 52-week high and 52-week low respectively. Overall, ABCL moved -18.82% over the past month.
AbCellera Biologics Inc’s market cap currently stands at around $1.13 billion.
Analysts have a consensus estimate of 9.95M for the company’s revenue for the quarter, with a low and high estimate of 8.9M and 18.29M respectively. The average forecast suggests down to a -18.40% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 47.55M, representing a 25.00% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ABCL is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
ABCL’s current price about -3.77% and -13.06% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 41.02, while 7-day volatility ratio is 6.96% and 5.91% in the 30-day chart. Further, AbCellera Biologics Inc (ABCL) has a beta value of 0.44, and an average true range (ATR) of 0.25.
If we refocus on AbCellera Biologics Inc (NASDAQ:ABCL), historical trading data shows that trading volumes averaged 1.40 million over the past 3 months. The company’s latest data on shares outstanding shows there are 290.82 million shares.
The 29.92% of AbCellera Biologics Inc’s shares are in the hands of company insiders while institutional holders own 37.52% of the company’s shares. Current price change has pushed the stock -32.75% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ABCL stock continues to rise going into the next quarter.